These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35777866)

  • 1. Anticalin®-based therapeutics: Expanding new frontiers in drug development.
    Morales-Kastresana A; Siegemund M; Haak S; Peper-Gabriel J; Neiens V; Rothe C
    Int Rev Cell Mol Biol; 2022; 369():89-106. PubMed ID: 35777866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticalin
    Rothe C; Skerra A
    BioDrugs; 2018 Jun; 32(3):233-243. PubMed ID: 29748739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticalin® proteins: from bench to bedside.
    Deuschle FC; Ilyukhina E; Skerra A
    Expert Opin Biol Ther; 2021 Apr; 21(4):509-518. PubMed ID: 33074019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class.
    Gille H; Hülsmeyer M; Trentmann S; Matschiner G; Christian HJ; Meyer T; Amirkhosravi A; Audoly LP; Hohlbaum AM; Skerra A
    Angiogenesis; 2016 Jan; 19(1):79-94. PubMed ID: 26650228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-targeting antibody-anticalin fusion proteins for in vivo pretargeting applications.
    Steiner M; Gutbrodt K; Krall N; Neri D
    Bioconjug Chem; 2013 Feb; 24(2):234-41. PubMed ID: 23350721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elarekibep (PRS-060/AZD1402), a new class of inhaled Anticalin medicine targeting IL-4Ra for type 2 endotype asthma.
    Matschiner G; Fitzgerald MF; Moebius U; Hohlbaum AM; Gille H; Jensen K; Kirchfeld K; Rattenstetter B; Laforge A; Bel Aiba RS; Ciccotosto J; Nyugen H; Foster ML; Snouwaert JN; Nguyen M; Koller BH; Matis L; Anderson GP; Olwill SA
    J Allergy Clin Immunol; 2023 Apr; 151(4):966-975. PubMed ID: 36592703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Localized Costimulatory T-Cell Engagement by the 4-1BB/HER2 Bispecific Antibody-Anticalin Fusion PRS-343.
    Hinner MJ; Aiba RSB; Jaquin TJ; Berger S; Dürr MC; Schlosser C; Allersdorfer A; Wiedenmann A; Matschiner G; Schüler J; Moebius U; Rothe C; Matis L; Olwill SA
    Clin Cancer Res; 2019 Oct; 25(19):5878-5889. PubMed ID: 31138587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic Engineering of OX40-Blocking Anticalin Proteins Using Monomeric Plasma Half-Life Extension Domains.
    Siegemund M; Oak P; Hansbauer EM; Allersdorfer A; Utschick K; Winter A; Grasmüller C; Galler G; Mayer JP; Weiche B; Prassler J; Kontermann RE; Rothe C
    Front Pharmacol; 2021; 12():759337. PubMed ID: 34759826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a high affinity Anticalin
    Deuschle FC; Morath V; Schiefner A; Brandt C; Ballke S; Reder S; Steiger K; Schwaiger M; Weber W; Skerra A
    Theranostics; 2020; 10(5):2172-2187. PubMed ID: 32089738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-human phase I study of PRS-050 (Angiocal), an Anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors.
    Mross K; Richly H; Fischer R; Scharr D; Büchert M; Stern A; Gille H; Audoly LP; Scheulen ME
    PLoS One; 2013; 8(12):e83232. PubMed ID: 24349470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer.
    Terwisscha van Scheltinga AG; Lub-de Hooge MN; Hinner MJ; Verheijen RB; Allersdorfer A; Hülsmeyer M; Nagengast WB; Schröder CP; Kosterink JG; de Vries EG; Audoly L; Olwill SA
    J Nucl Med; 2014 Apr; 55(4):665-71. PubMed ID: 24614223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality.
    Aubrey N; Gouilleux-Gruart V; Dhommée C; Mariot J; Boursin F; Albrecht N; Bergua C; Croix C; Gilotin M; Haudebourg E; Horiot C; Matthias L; Mouline C; Lajoie L; Munos A; Ferry G; Viaud-Massuard MC; Thibault G; Velge-Roussel F
    Antibodies (Basel); 2022 Aug; 11(3):. PubMed ID: 35997348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold.
    Schlehuber S; Skerra A
    Biol Chem; 2001 Sep; 382(9):1335-42. PubMed ID: 11688717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein.
    Masuda Y; Yamaguchi S; Suzuki C; Aburatani T; Nagano Y; Miyauchi R; Suzuki E; Yamamura N; Nagatomo K; Ishihara H; Okuno K; Nara F; Matschiner G; Hashimoto R; Takahashi T; Nishizawa T
    J Pharmacol Exp Ther; 2018 May; 365(2):368-378. PubMed ID: 29463608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice.
    Deuschle FC; Schiefner A; Brandt C; Skerra A
    Protein Sci; 2020 Aug; 29(8):1774-1783. PubMed ID: 32463547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of platform process development approaches to the manufacturing of Mabcalin™ bispecifics.
    Wachter S; Angevin T; Bubna N; Tan A; Cichy A; Brown D; Wolfe LS; Sappington R; Lilla E; Berry L; Grismer D; Orth C; Blanusa M; Mostafa S; Kaufmann H; Felderer K
    J Biotechnol; 2023 Nov; 377():13-22. PubMed ID: 37820750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput sorting of an Anticalin library via EspP-mediated functional display on the Escherichia coli cell surface.
    Binder U; Matschiner G; Theobald I; Skerra A
    J Mol Biol; 2010 Jul; 400(4):783-802. PubMed ID: 20630471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of Alzheimer
    Eichinger A; Rauth S; Hinz D; Feuerbach A; Skerra A
    Biol Chem; 2022 Apr; 403(5-6):557-571. PubMed ID: 35355502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.